Antibacterial Nanoparticles Therapeutic (ANT) Study
Overview
- Response deadline
- 2:00 PM EDT
- Posted
- April 14, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- ARMY MED RES ACQ ACTIVITY
- Place of performance
- Silver Spring, Maryland, 20910
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- PANDHA-26-P-0000_036893
- Notice ID
- 68fa274eefb242f796d5ee5a4d4d3c37
Description
The University of Notre Dame will conduct a study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. There is a need to bring novel therapeutics to the military health care to treat MDR P. aeruginosa. The collaborative partner of this study is the University of Notre Dame, the patent owner of a unique technology (phage-mimicking nanoparticles) that provides life-saving therapeutics for service members and civilians. This technology was awarded a patent in 2024 - US-12161725-B2. Government anticipates that the collaborative efforts will contribute to Food and Drug Administration (FDA) approval of this innovative therapy, leading to reduced morbidity and mortality rates, enhanced operational readiness, advanced combat medicine, and substantial contributions to broader biosecurity initiatives and civilian health improvements.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Lifecycle
- 4Version 4Sources SoughtArchived
Antibacterial Nanoparticles Therapeutic (ANT) Study
- 5Version 5Special NoticeArchivedCurrent
Type changed from Sources Sought to Special Notice
Antibacterial Nanoparticles Therapeutic (ANT) Study
- 9Version 9Award NoticeArchived
Type changed from Special Notice to Award Notice
Antibacterial Nanoparticles Therapeutic (ANT) Study
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
PANDHA-26-P-0000_036893
Archive Date
May 13, 2026
Office Address
FORT DETRICK, MD, 21702